Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 antagonize TNF-α-stimulated neutrophil-enterocyte interactions in vitro and attenuate TNF-α-induced chemokine release and colonocyte apoptosis in human intestinal mucosa ex vivo

Journal of Immunology

Volumn 167, Issue 5, 2001, Pages 2772-2780

  Goh, J ^a   Baird, A W ^a   O'Keane, C ^a   Watson, R W G ^a   Cottell, D ^a   Bernasconi, G ^a   Petasis, N A ^a   Godson, C ^a   Brady, H R ^a   MacMathuna, P ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

15 EPILIPOXIN A; 16 PHENOXY 11,12 DEHYDRO 17,18,19,20 TETRANORLIPOXIN A METHYL ESTER; ACETYLSALICYLIC ACID; ALPHA CHEMOKINE; BETA CHEMOKINE; CASPASE 3; CHEMOKINE; ICOSANOID; INTERLEUKIN 8; LIPOXIN A; LIPOXYGENASE; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL INTERACTION; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MECHANISM; ENTERITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INTESTINE CELL; LEUKOCYTE ADHERENCE; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0035451814     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.5.2772     Document Type: Article

References (48)

1. Just how inflamed is the normal gut?
2. Review article: Pathobiology of neutrophil interaction with intestinal epithelia
3. Current theories on the causes of inflammatory bowel disease
4. Inflammatory bowel disease: Etiology and pathogenesis
5. Role of neutrophils in the pathogenesis of inflammatory bowel disease
6. Effects of polymorphonuclear leukocyte transmigration on the barrier function of cultured intestinal epithelial monolayers
7. Neutrophil migration across a cultured intestinal epithelium: Dependence on a CD11b/CD18 mediated event and enhanced efficiency in physiological direction
8. 4 modulates transmigration of human neutrophils across intestinal epithelial monolayers
9. Chemokines in the inflammatory bowel diseases
10. Differential and regulated expression of C-X-C, C-C and C-chemokines by human colon epithelial cells
11. Monocyte-chemoattractant protein I gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa
12. Interleukin 8: Cells of origin in inflammatory bowel disease
13. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease
14. Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): A jungle of cell-cell interactions or a therapeutic opportunity?
15. Lipoxins: Putative braking signals in host defence, inflammation and hypersensitivity
16. 4 stable analogs that block transmigration and adhesion of human neutrophils
17. Lipoxins: Novel anti-inflammatory therapeutics?
18. 4 stable analogs are demonstrable in human whole blood: Modulation of leukocyte adhesion molecules and inhibition of neutrophil-endothelial interactions
19. 4 inhibit leukotriene-stimulated interaction of human neutrophils and endothelial cells
20. 4 inhibits IL-1βinduced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases
21. 4 receptor that is regulated by interleukin (IL)-13 and interferon γ and inhibits tumor necrosis factor α-induced IL-8 release
22. Cutting edge: Lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages
23. 4 analogs
24. Established intestinal cell lines as model systems for electrolyte transport studies
25. Immunohistochemical analysis of in-vivo patterns of expression of CPP32 (caspase-3), a cell death protease
26. Expression and polarization of ICAM-1 on intestinal epithelia: Consequences for CD11b/CD18-mediated interactions with neutrophils
27. Surface attachment of Salmonella typhimurium to intestinal epithelia imprints the subepithelial matrix with gradients for neutrophils
28. Neutrophil migration across model intestinal epithelia: Monolayer disruption and subsequent events in epithelial repair
29. C-X-C and C-C chemokine expression and secretion by the human colonic epithelial cell line, HT 29: Differential effect of T lymphocyte-derived cytokines
30. Interleukin-8 production by the human colon epithelial cell line HT-29: Modulation by interleukin 13
31. IL-8 secretion and neutrophil activation by HT-29 colonic epithelial cells
32. The C-X-C chemokine ENA-78 is preferentially expressed in intestinal epithelium in inflammatory bowel disease
33. Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-α and Fas antigen
34. Apoptosis of human epithelial cells after bacterial invasion
35. Susceptibility to Fas-induced apoptosis in human nontumoral enterocyte: Role of costimulatory factors
36. NF-κB signaling proteins as therapeutic targets for inflammatory bowel diseases
37. 2+-mediated activation of the NF-κB pathway
38. An essential role for NF-κB in preventing TNF-α-induced cell death
39. Apoptosis: Implications for inflammatory bowel disease
40. TNF-α-induced IEC-6 cell apoptosis requires activation of ICE caspases whereas complete inhibition of the caspase cascade leads to necrotic cell death
41. 4 inhibit tumor necrosis factor 1-α initiated neutrophil responses and trafficking: Regulators of a cytokine-chemokine axis
42. 4 in renal mesangial cells: Differential activation of MAP kinases through distinct receptors
43. Renal allograft rejection: β-chemokine involvement in the development of tubulitis
44. The -403 G→A promoter polymorphism in the RANTES gene is associated with atopy and asthma
45. A comparison of cytokine responses in respiratory syncytial virus and influenza A infections in infants
46. Cyclooxygenase: A target for colon cancer prevention
47. The relationship between cyclooxygenase-2 expression and colorectal cancer
48. Effects of nonsteroidal anti-inflammatory drugs on inflammatory bowel disease: A case-control study